Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11532686 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Conditions: Chronic Kidney Disease;   Cardiovascular Disease
Interventions: Drug: Spironolactone;   Drug: Placebo

Indicates status has not been verified in more than two years